Good health is the foundation of vibrant lives and thriving communities. Thanks to decades of medical and scientific advancement, we live in a time where access to innovation means that many previously devastating diseases can be managed or even cured.
But how are we addressing the areas where challenges remain and patient needs are still unmet?
In this series, we speak with leading experts for insights into how we can unlock the medicines of tomorrow and get transformative treatments to people in as quickly as possible.
From research and development, to regulatory and approval processes, it is our belief that sharing insights on each part of the healthcare ecosystem can help transform patient experiences and outcomes.
This recording was organised and funded by Johnson & Johnson
June 2024
CP-460011
Hosted on Acast. See acast.com/privacy for more information.
Good health is the foundation of vibrant lives and thriving communities. Thanks to decades of medical and scientific advancement, we live in a time where access to innovation means that many previously devastating diseases can be managed or even cured.
But how are we addressing the areas where challenges remain and patient needs are still unmet?
In this series, we speak with leading experts for insights into how we can unlock the medicines of tomorrow and get transformative treatments to people in as quickly as possible.
From research and development, to regulatory and approval processes, it is our belief that sharing insights on each part of the healthcare ecosystem can help transform patient experiences and outcomes.
This recording was organised and funded by Johnson & Johnson
June 2024
CP-460011
Hosted on Acast. See acast.com/privacy for more information.
In this episode, we’re looking at the unique approach France has taken to try and get new and innovative treatments to patients faster, and what other national health bodies could learn from this process.
Joining us is an expert in market access and health policy, who has been at the forefront of recent regulatory changes in France and brings with her a wealth of knowledge from a career spanning three decades in pharmaceuticals.
This recording was organised and funded by Johnson & Johnson
June 2024
CP-460651
Hosted on Acast. See acast.com/privacy for more information.